Literature DB >> 11726519

Functional interaction of STAT5 and nuclear receptor co-repressor SMRT: implications in negative regulation of STAT5-dependent transcription.

H Nakajima1, P K Brindle, M Handa, J N Ihle.   

Abstract

Signal transducers and activators of transcription (STATs) play a central role in cytokine signaling. Activating and repressing gene transcription is a dynamic process involving chromatin remodeling by histone acetylases and deacetylases, yet the role of this process in STAT-dependent transcription remains largely unknown. In a search for STAT5-interacting proteins by yeast two-hybrid screening, we identified the nuclear receptor co-repressor SMRT (silencing mediator for retinoic acid receptor and thyroid hormone receptor) as a potential STAT5-binding partner. SMRT binds to both STAT5A and 5B, and strongly repressed STAT5-dependent transcription in vitro. SMRT binds to the N-terminal coiled-coil domain of STAT5 and a mutation within this region previously found to render STAT5 hyperactive in response to cytokines abolished the interaction with SMRT. Overexpression of SMRT suppressed the induction of STAT5 target genes by interleukin-3, whereas the histone deacetylase inhibitor trichostatin A effectively enhanced and prolonged their expression. Together, these findings illuminate the potential role of SMRT in down-regulating STAT5 activity, with a consequent reduction of STAT5 target gene expression.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11726519      PMCID: PMC125765          DOI: 10.1093/emboj/20.23.6836

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  31 in total

1.  Corepressor SMRT binds the BTB/POZ repressing domain of the LAZ3/BCL6 oncoprotein.

Authors:  P Dhordain; O Albagli; R J Lin; S Ansieau; S Quief; A Leutz; J P Kerckaert; R M Evans; D Leprince
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-30       Impact factor: 11.205

Review 2.  Jaks and STATs: biological implications.

Authors:  W J Leonard; J J O'Shea
Journal:  Annu Rev Immunol       Date:  1998       Impact factor: 28.527

3.  Functionally distinct isoforms of STAT5 are generated by protein processing.

Authors:  M Azam; C Lee; I Strehlow; C Schindler
Journal:  Immunity       Date:  1997-06       Impact factor: 31.745

4.  The transcriptional co-activator p/CIP binds CBP and mediates nuclear-receptor function.

Authors:  J Torchia; D W Rose; J Inostroza; Y Kamei; S Westin; C K Glass; M G Rosenfeld
Journal:  Nature       Date:  1997-06-12       Impact factor: 49.962

Review 5.  STATs and gene regulation.

Authors:  J E Darnell
Journal:  Science       Date:  1997-09-12       Impact factor: 47.728

6.  Role of the histone deacetylase complex in acute promyelocytic leukaemia.

Authors:  R J Lin; L Nagy; S Inoue; W Shao; W H Miller; R M Evans
Journal:  Nature       Date:  1998-02-19       Impact factor: 49.962

7.  Nuclear receptor repression mediated by a complex containing SMRT, mSin3A, and histone deacetylase.

Authors:  L Nagy; H Y Kao; D Chakravarti; R J Lin; C A Hassig; D E Ayer; S L Schreiber; R M Evans
Journal:  Cell       Date:  1997-05-02       Impact factor: 41.582

8.  Specific inhibition of Stat3 signal transduction by PIAS3.

Authors:  C D Chung; J Liao; B Liu; X Rao; P Jay; P Berta; K Shuai
Journal:  Science       Date:  1997-12-05       Impact factor: 47.728

9.  Transcription factor-specific requirements for coactivators and their acetyltransferase functions.

Authors:  E Korzus; J Torchia; D W Rose; L Xu; R Kurokawa; E M McInerney; T M Mullen; C K Glass; M G Rosenfeld
Journal:  Science       Date:  1998-01-30       Impact factor: 47.728

10.  Identification and characterization of a constitutively active STAT5 mutant that promotes cell proliferation.

Authors:  M Onishi; T Nosaka; K Misawa; A L Mui; D Gorman; M McMahon; A Miyajima; T Kitamura
Journal:  Mol Cell Biol       Date:  1998-07       Impact factor: 4.272

View more
  38 in total

1.  Opposing regulation of the locus encoding IL-17 through direct, reciprocal actions of STAT3 and STAT5.

Authors:  Xiang-Ping Yang; Kamran Ghoreschi; Scott M Steward-Tharp; Jaime Rodriguez-Canales; Jinfang Zhu; John R Grainger; Kiyoshi Hirahara; Hong-Wei Sun; Lai Wei; Golnaz Vahedi; Yuka Kanno; John J O'Shea; Arian Laurence
Journal:  Nat Immunol       Date:  2011-01-30       Impact factor: 25.606

2.  Chromatin acetylation and remodeling at the Cis promoter during STAT5-induced transcription.

Authors:  Anne Rascle; Emma Lees
Journal:  Nucleic Acids Res       Date:  2003-12-01       Impact factor: 16.971

3.  Deacetylase activity is required for recruitment of the basal transcription machinery and transactivation by STAT5.

Authors:  Anne Rascle; James A Johnston; Bruno Amati
Journal:  Mol Cell Biol       Date:  2003-06       Impact factor: 4.272

4.  A developmentally controlled competitive STAT5-PU.1 DNA binding mechanism regulates activity of the Ig κ E3' enhancer.

Authors:  Suchita Hodawadekar; Kyoungsook Park; Michael A Farrar; Michael L Atchison
Journal:  J Immunol       Date:  2012-01-25       Impact factor: 5.422

Review 5.  Signal transducer and activator of transcription (STAT) signalling and T-cell lymphomas.

Authors:  Tracey J Mitchell; Susan John
Journal:  Immunology       Date:  2005-03       Impact factor: 7.397

Review 6.  Roles and regulation of stat family transcription factors in human breast cancer.

Authors:  Charles V Clevenger
Journal:  Am J Pathol       Date:  2004-11       Impact factor: 4.307

7.  STAT5 acts as a repressor to regulate early embryonic erythropoiesis.

Authors:  Matthew Schmerer; Ingrid Torregroza; Aude Pascal; Muriel Umbhauer; Todd Evans
Journal:  Blood       Date:  2006-07-11       Impact factor: 22.113

Review 8.  From the diet to the nucleus: vitamin A and TGF-beta join efforts at the mucosal interface of the intestine.

Authors:  Daniel Mucida; Yunji Park; Hilde Cheroutre
Journal:  Semin Immunol       Date:  2008-09-21       Impact factor: 11.130

9.  STAT5B: A Differential Regulator of the Life and Death of CD4+ Effector Memory T Cells.

Authors:  Sonia S Majri; Jill M Fritz; Alejandro V Villarino; Lixin Zheng; Chrysi Kanellopoulou; Benjamin Chaigne-Delalande; Juha Grönholm; Julie E Niemela; Behdad Afzali; Matthew Biancalana; Stefania Pittaluga; Ashleigh Sun; José L Cohen; Steven M Holland; John J O'Shea; Gulbu Uzel; Michael J Lenardo
Journal:  J Immunol       Date:  2017-11-29       Impact factor: 5.422

10.  STAT5 requires the N-domain for suppression of miR15/16, induction of bcl-2, and survival signaling in myeloproliferative disease.

Authors:  Geqiang Li; Kristy L Miskimen; Zhengqi Wang; Xiu Yan Xie; Jennifer Brenzovich; John J Ryan; William Tse; Richard Moriggl; Kevin D Bunting
Journal:  Blood       Date:  2009-12-14       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.